FINWIRES · TerminalLIVE
FINWIRES

Euroz Hartleys表示,Amplitude Energy目前的股价代表着极具吸引力的买入机会。

By

-- Euroz Hartleys周一发布的一份报告指出,Amplitude Energy(ASX:AEL)预计将在第四财季取得创纪录的业绩,目前股价极具吸引力,是值得买入的良机。 这家股票研究公司表示,由于维多利亚州Orbost天然气资产持续推进产能提升,其他盆地(包括库珀盆地Callawonga新油井)的增产,以及现货天然气价格的预期上涨,预计该公司第四财季业绩将表现良好。 Euroz Hartleys预测Amplitude第四财季的天然气产量将达到7拍焦耳当量,营收为8670万澳元。该公司还将Amplitude本财年的资本支出预期下调至1.36亿澳元,从而降低了其预计的年末净债务水平。 此外,Euroz Hartleys表示,鉴于该公司东海岸供应项目“位于奥特威盆地核心产区,且目标区域具有引人注目的地球物理特征和简单的圈闭几何结构”,该公司对该项目二期工程的成果充满信心。 这家股票研究公司维持对该公司的“买入”评级,并将目标股价从每股3.25澳元上调至3.40澳元,反映了更新后的风险分部估值。 Amplitude Energy的股价在周一的交易中下跌了1%。

Related Articles

Asia

Dongjiang Environmental's Loss Widens 2.7% in Q1

Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.

$HKG:0895$SHE:002672
Sectors

Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday

Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.

$IBB$LGND$OGN$ORKA$XLV$XOMA
Asia

Zuoli Kechuang Logs Drop in Q1 Profit

Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.

$HKG:6866